Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $863.34M · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: CRTO stock price vs AMRN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AMRN's multiple
Needs AMRN P/E.
Implied fair value · at CRTO's multiple
Needs EPS (TTM) is negative, CRTO P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CRTO FY 2025 (ended Dec 31, 2025) · AMRN FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 96% equity / 4% debt · EV / Revenue 0.28x · EV / EBITDA 1.61x
Capital structure 97% equity / 3% debt · EV / Revenue 26.21x
AMRN carries the larger enterprise value at $5.60B against $534.90M; CRTO trades on the lower EV / Revenue multiple (0.28x vs 26.21x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
CRITEO S.A. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
AMARIN CORP PLC\UK · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.03x
0.39x
Net debt / EBITDA
Leverage against operating earnings
-0.99x
3.79x
Cash and equivalents
Liquid reserves on the balance sheet
$365.28M
$302.59M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Trade Desk, Inc.
CRTO vs TTD
MAGNITE, INC.
CRTO vs MGNI
PubMatic, Inc.
CRTO vs PUBM
LIGAND PHARMACEUTICALS INC
CRTO vs LGND
Harmony Biosciences Holdings, Inc.
CRTO vs HRMY
SUPERNUS PHARMACEUTICALS, INC.
CRTO vs SUPN
Viatris Inc
CRTO vs VTRS
Organon & Co.
CRTO vs OGN
INCYTE CORP
CRTO vs INCY
$36.84M
$177.39M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
